AltMountain

Med III B S.L.P.

Lyon, France · CIK 1878039
Offshore
Status: no Form D since Aug 2021. Funds file a Form D when they begin selling and amend it each year while the offering continues, so this fund has most likely stopped raising money. It may still be investing, or it may have closed or been dissolved. The details below are from its latest filing, kept here as a record.

Med III B S.L.P. is a private equity fund based in Lyon, France. According to its most recent Form D, filed Aug 13, 2021, it has sold $25,231,855 of interests to 12 investors since its first sale in Aug 2021. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Med III GP; ArchiMed SAS.

Total raised
$25,231,855Cumulative sales reported on Form D
Investors
12
First sale
Aug 2, 2021
Minimum investment
None set
Who can invest
Qualified purchasersSection 3(c)(7): generally $5M+ in investments
Offering exemption
Rule 506(b)No general advertising
Key people and entities
Med III GP; ArchiMed SAS
Latest Form D
Aug 13, 2021

From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction⁠​​‌‌‌‌‌‌‌​‌‌‌‌‌‌‌‌​‌⁠

Questions about Med III B S.L.P.

What is the minimum investment for Med III B S.L.P.?

Med III B S.L.P.'s latest Form D, filed Aug 13, 2021, does not set a minimum investment. Managers can still require one in the offering documents.

Who can invest in Med III B S.L.P.?

Med III B S.L.P. is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.

How much has Med III B S.L.P. raised?

Med III B S.L.P. reports $25,231,855 sold from 12 investors on its Form D filed Aug 13, 2021. This is cumulative sales since the offering began, not current assets or performance.

Where is Med III B S.L.P. based?

Med III B S.L.P. is based in Lyon, France.

When did Med III B S.L.P. launch?

Med III B S.L.P. reports its first sale in Aug 2021.

Size compared with every private equity fund

Raised more than 64% of the 22 private equity funds based in France, and more than 55% of all 8,931 that report sales.

Other funds with the same team

Similar-size private equity funds in France

All private equity funds in France